An intestinal dysbacteriosis as a side-effect of anti-helicobacter therapy

After anti-Helicobacter therapy 55 patients with duodenal ulcer and clinical signs of intestinal dysbacteriosis were under observation. We examined microbe spectrum of intestine before and after treatment by Colibacterin and Biofl orum. And the effectiveness of these medicines have compared. As a re...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Omarova, T. R. Omarov
Format: Article
Language:Russian
Published: Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) 2014-09-01
Series:Сеченовский вестник
Subjects:
Online Access:https://www.sechenovmedj.com/jour/article/view/760
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:After anti-Helicobacter therapy 55 patients with duodenal ulcer and clinical signs of intestinal dysbacteriosis were under observation. We examined microbe spectrum of intestine before and after treatment by Colibacterin and Biofl orum. And the effectiveness of these medicines have compared. As a result of therapy by Colibacterin and Bioflorum, the reduction of clinical and microbiological signs of intestinal dysbacteriosis in two groups are remarked. There was detected the effectiveness of Bioflorum by the period of reduction of clinical signs and recovery of large intestine’ microflora. So, we recommend Bioflorum in the complex therapy under the control of microbial spectrum to the patients with duodenal ulcer.
ISSN:2218-7332
2658-3348